About ProSpec
ProSpec is a company based in Ness Ziona (Israel) founded in 1998. ProSpec offers products and services including Recombinant Proteins, Monoclonal Antibodies, Cytokines, and Growth Factors. ProSpec operates in a competitive market with competitors including Medeloop, Hyku Biosciences, Sirion Biotech, Metagen Therapeutics and Procognia, among others.
- Headquarter Ness Ziona, Israel
- SectorsHealthcare
- Email••••••••
- Website prospecbio.com
- Legal Name Prospec-Tany Technogene Ltd.
- Investors
Products & Services of ProSpec
ProSpec offers a comprehensive portfolio of products and services, including Recombinant Proteins, Monoclonal Antibodies, Cytokines, and Growth Factors.
Engineered proteins for research and development applications.
Antibodies used in scientific and diagnostic studies.
Signaling molecules for cell biology research.
Factors that promote cell growth in experiments.
Funding Insights of ProSpec
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of ProSpec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2014 | – | Grant | – | – |
1 investors in total: 1 institutional.
Investors in ProSpec
ProSpec has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for ProSpec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ProSpec
2 dated milestones of ProSpec across 16 years, from founding to its latest funding, stage changes and deals.
- Founded ProSpec is founded.
- Funding First funding round.
Competitors of ProSpec
ProSpec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medeloop, Hyku Biosciences, Sirion Biotech, Metagen Therapeutics and Procognia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medeloop.ai | 2021 | Palo Alto, United States | $23.5M | – | Drug discovery services are offered by Medeloop as a CRO. | |
| hykubiosciences.com | 2023 | Lexington, United States | $56M | – | Covalent medicines platform is advanced for drug discovery targeting proteins. | |
| sirion-biotech.com | 2005 | Planegg, Germany | – | 42 | Customized AAV-based viral vectors for gene therapy are supplied. | |
| metagentx.com | 2020 | Tokyo, Japan | $15.72M | – | CRO focused on providing microbiome drug discovery and development services | |
| procognia.com | 2000 | Rehovot, Israel | $23.76M | – | Contract research services for glycosylation and protein function studies | |
| centivax.com | 2019 | San Francisco, United States | $55M | – | Drug discovery services are provided to pharmaceutical and biotech clients. | |
| purebiologics.com | 2010 | Wroclaw, Poland | $2.6M | – | Specialized CRO with expertise in recombinant protein production and purification | |
| sanyoubio.com | 2015 | Shanghai, China | – | – | CRO focused on providing cell and molecular biology services for antibody drug discovery | |
| inbiome.com | 2019 | Amsterdam, Netherlands | – | – | Molecular culture development is specialized in by Inbiome CRO. | |
| biointron.com | 2012 | Taizhou, China | – | – | Antibody-drug research and development services are provided. |
Detailed competitors of ProSpec
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ProSpec
The website of ProSpec (prospecbio.com) receives about 53.2K visits a month.
- Monthly visits53.2K
▲ 9% vs previous month
Websites whose visitors overlap most with ProSpec. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abnova.com | 100% | 30.7K | #957,320 | View details | |
cytokinecenter.com | cytokinecenter.com | 100% | – | – | – |
| biolegend.com | 94% | 229.6K | #142,656 | View details | |
| genaxxon.com | 88% | 16.5K | #1,573,860 | View details | |
| anaspec.com | 88% | 30.1K | #1,080,158 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for ProSpec
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to ProSpec
10 companies that operate in the same segment as ProSpec (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ProSpec
ProSpec was founded in 1998 and raised its 1st funding round 16 years after it was founded.
ProSpec is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
Founded in 1998 and based in Ness Ziona, Israel, ProSpec operates in the biotechnology sector. Purified recombinant proteins are produced for applications in cancer, apoptosis, endocrinology, immunology, neuroscience, and stem cell research. Products encompass interferons, interleukins, growth factors, chemokines, antibodies, enzymes, and viral antigens. Services provided include DNA cloning, protein expression, monoclonal antibody development, fermentation, and technology licensing.
ProSpec's top competitors include Medeloop, Pure Biologics and Centivax.
ProSpec offers Recombinant Proteins, Monoclonal Antibodies, Cytokines, and Growth Factors.
ProSpec has 1 investor. Key investors include European Union.
ProSpec operates through Prospec-Tany Technogene Ltd..